SCHEMBL4074192

SCHEMBL4074192

NC1CC1.O=C(O)c1cccc2sc(-c3nc(Cl)ncc3Br)cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.37
CAMKK2 Q96RR4 1/20 0.32
CHEK1 O14757 2/20 0.32
ABL1 P00519 2/20 0.31
BCR P11274 2/20 0.31
MERTK Q12866 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
RXFP1 Q9HBX9 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
PPARG P37231 1/20 0.31
NCOA2 Q15596 1/20 0.31
NCOA1 Q15788 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HAVCR2 Q8TDQ0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3961528 0.93 BTK (0.41) BTKABL1BCRMEN1KMT2A
SCHEMBL3965319 0.83 RAB9A (0.42) BTKMEN1KMT2AKDM4EALDH1A1
SCHEMBL3961637 0.82 BTK (0.39) BTKMEN1KMT2ARXFP1KDM4E
SCHEMBL3965410 0.81 BTK (0.41) BTKMEN1KMT2AKDM4EALDH1A1
SCHEMBL3965727 0.80 KDM4E (0.34) MEN1KMT2ARXFP1KDM4EALDH1A1
SCHEMBL3970415 0.80 PDK1 (0.38) MEN1KMT2ARXFP1KDM4EALDH1A1
Hydrochloric Acid SCHEMBL4075875 0.76 MERTK (0.35) MERTK
SCHEMBL3969565 0.74 BTK (0.38) BTKCHEK1KMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL4069329 0.74 MERTK (0.36) MERTK
SCHEMBL3961444 0.71 L3MBTL1 (0.48) KMT2AKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989200-B1 [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES LILLY CO ELI (US) 2009-07-29 EP disclosed